BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  STRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate Update

  May 8, 2025

   · 

  3 min read
• Press Releases

  Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Tuesday, May 13, 2025

  May 8, 2025

   · 

  2 min read
• Press Releases

  Radiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global Conference

  May 8, 2025

   · 

  1 min read
• Press Releases

  Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference

  May 8, 2025

   · 

  1 min read
• Press Releases

  Study shows patients treated with Smith+Nephew’s CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹*

  May 8, 2025

   · 

  6 min read
• Press Releases

  Valitor Presents Multiple Preclinical Datasets on the Potential of its Innovative Anti-VEGF Therapy Dosed Twice Yearly for Wet AMD at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

  May 8, 2025

   · 

  5 min read
• Press Releases

  Krystal Biotech to Present at BofA Securities 2025 Health Care Conference

  May 8, 2025

   · 

  1 min read
• Press Releases

  New Preclinical Data for Assembly Biosciences’ Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress 2025

  May 8, 2025

   · 

  6 min read
• Press Releases

  Annexon to Present on the Neuroprotective Effects of ANX007 at the 2025 ARVO Annual Meeting and the Retina World Congress

  May 8, 2025

   · 

  9 min read
• Press Releases

  ARS Pharmaceuticals’ neffy® (epinephrine nasal spray) 1 mg is Now Available in the United States for Type I Allergic Reactions, including Anaphylaxis, in Pediatric Patients Weighing 15 to < 30 Kilograms

  May 8, 2025

   · 

  11 min read